| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.796 | 0.003 | 0.796 | Anesthetic local | 0.367 0.008 CID_115282 | ||
| 0.536 | 0.016 | 0.633 | Calcium channel L-type activator | 0.633 0.004 CID_115282 | CID_115282 | |
| 0.421 | 0.006 | 0.421 | Nav1.2 sodium channel blocker | 0.186 0.04 CID_115282 | ||
| 0.423 | 0.019 | 0.423 | Psychostimulant | 0.336 0.034 CID_115282 | ||
| 0.403 | 0.005 | 0.403 | Nav1.3 sodium channel blocker | 0.311 0.008 CID_115282 | ||
| 0.444 | 0.086 | 0.444 | Caspase 9 stimulant | 0.332 0.161 CID_115282 | ||
| 0.357 | 0.023 | 0.357 | Anesthetic general | 0.2 0.074 CID_115282 | ||
| 0.334 | 0.015 | 0.334 | Gastrin inhibitor | 0.297 0.035 CID_115282 | ||
| 0.32 | 0.028 | 0.32 | Ca(v)3.3 blocker | 0.238 0.119 CID_115282 | ||
| 0.312 | 0.037 | 0.312 | Sigma receptor agonist | 0.128 0.104 CID_115282 | ||
| 0.302 | 0.029 | 0.302 | 5 Hydroxytryptamine 1E antagonist | 0.271 0.053 CID_115282 | ||
| 0.379 | 0.12 | 0.46 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.46 0.055 CID_115282 | CID_115282 | |
| 0.273 | 0.019 | 0.273 | Antipruritic | 0.153 0.091 CID_115282 | ||
| 0.24 | 0.004 | 0.24 | Sphingosine 1-phosphate receptor 5 antagonist | 0.194 0.014 CID_115282 | ||
| 0.294 | 0.059 | 0.294 | Transcription factor STAT inhibitor | 0.279 0.068 CID_115282 | ||
| 0.238 | 0.004 | 0.238 | Sphingosine 1-phosphate receptor 2 antagonist | 0.173 0.019 CID_115282 | ||
| 0.236 | 0.011 | 0.236 | Nav1.6 sodium channel blocker | 0.152 0.051 CID_115282 | ||
| 0.338 | 0.115 | 0.338 | Analgesic | 0.336 0.116 CID_115282 | ||
| 0.277 | 0.061 | 0.277 | Interleukin agonist | 0.213 0.109 CID_115282 | ||
| 0.277 | 0.065 | 0.277 | Transcription factor STAT3 inhibitor | 0.253 0.081 CID_115282 | ||
| 0.216 | 0.014 | 0.216 | Falcipain 3 inhibitor | 0.113 0.059 CID_115282 | ||
| 0.279 | 0.079 | 0.279 | Spasmolytic | 0.22 0.105 CID_115282 | ||
| 0.292 | 0.094 | 0.292 | Vasodilator, coronary | 0.241 0.143 CID_115282 | ||
| 0.205 | 0.008 | 0.205 | Sphingosine 1-phosphate receptor 4 antagonist | 0.18 0.014 CID_115282 | ||
| 0.268 | 0.08 | 0.367 | Insulysin inhibitor | 0.367 0.029 CID_115282 | CID_115282 | |
| 0.288 | 0.104 | 0.359 | Calcium channel activator | 0.359 0.044 CID_115282 | CID_115282 | |
| 0.237 | 0.062 | 0.237 | Anticonvulsant | 0.198 0.084 CID_115282 | ||
| 0.315 | 0.149 | 0.315 | 5 Hydroxytryptamine release inhibitor | 0.288 0.179 CID_115282 | ||
| 0.241 | 0.077 | 0.311 | Tyrosine 3 hydroxylase inhibitor | 0.311 0.028 CID_115282 | CID_115282 | |
| 0.202 | 0.042 | 0.202 | Acetylcholine M1 receptor antagonist | 0.121 0.107 CID_115282 | ||
| 0.192 | 0.031 | 0.192 | Neurotrophic factor | 0.174 0.041 CID_115282 | ||
| 0.196 | 0.037 | 0.196 | Neurotensin receptor agonist | 0.191 0.04 CID_115282 | ||
| 0.227 | 0.08 | 0.227 | Neuropeptide Y2 antagonist | 0.219 0.09 CID_115282 | ||
| 0.152 | 0.005 | 0.152 | Acetyl-CoA transferase inhibitor | 0.115 0.01 CID_115282 | ||
| 0.148 | 0.004 | 0.148 | Sphingosine kinase inhibitor | 0.141 0.004 CID_115282 | ||
| 0.275 | 0.134 | 0.275 | GABA C receptor rho-3 antagonist | 0.247 0.156 CID_115282 | ||
| 0.233 | 0.094 | 0.233 | Cardiotonic | |||
| 0.259 | 0.119 | 0.259 | Antithrombotic | |||
| 0.15 | 0.013 | 0.15 | Cannabinoid receptor agonist | |||
| 0.162 | 0.029 | 0.162 | Nav1.1 sodium channel blocker | |||
| 0.269 | 0.136 | 0.269 | Calpain 2 inhibitor | 0.237 0.158 CID_115282 | ||
| 0.277 | 0.145 | 0.277 | Beta lactamase inhibitor | 0.213 0.177 CID_115282 | ||
| 0.147 | 0.023 | 0.147 | Prolactin inhibitor | 0.105 0.051 CID_115282 | ||
| 0.128 | 0.006 | 0.128 | CC chemokine 5 receptor agonist | 0.097 0.026 CID_115282 | ||
| 0.124 | 0.004 | 0.124 | Sphingosine kinase 1 inhibitor | 0.119 0.004 CID_115282 | ||
| 0.133 | 0.012 | 0.187 | Nicotinic alpha4beta2 receptor antagonist | 0.187 0.005 CID_115282 | CID_115282 | |
| 0.218 | 0.099 | 0.313 | Superoxide dismutase inhibitor | 0.313 0.046 CID_115282 | CID_115282 | |
| 0.259 | 0.141 | 0.259 | Immunosuppressant | |||
| 0.126 | 0.011 | 0.126 | Sphingosine 1-phosphate receptor antagonist | 0.087 0.035 CID_115282 | ||
| 0.122 | 0.014 | 0.122 | Cannabinoid CB2 receptor agonist | |||
| 0.112 | 0.005 | 0.112 | Potassium channel (Tandem pore domain) blocker | 0.091 0.016 CID_115282 | ||
| 0.141 | 0.035 | 0.141 | Caspase 3 inhibitor | 0.106 0.082 CID_115282 | ||
| 0.12 | 0.014 | 0.12 | Cannabinoid CB1 receptor agonist | |||
| 0.209 | 0.105 | 0.209 | Calpain inhibitor | 0.194 0.119 CID_115282 | ||
| 0.212 | 0.112 | 0.263 | 5 Hydroxytryptamine release stimulant | 0.263 0.083 CID_115282 | CID_115282 | |
| 0.107 | 0.008 | 0.107 | Sphingosine 1-phosphate receptor 1 antagonist | 0.063 0.024 CID_115282 | ||
| 0.237 | 0.138 | 0.237 | Vasodilator, peripheral | |||
| 0.23 | 0.132 | 0.23 | Thyroid hormone beta antagonist | |||
| 0.15 | 0.052 | 0.15 | Cholinergic antagonist | 0.116 0.077 CID_115282 | ||
| 0.147 | 0.052 | 0.147 | Acetylcholine antagonist | 0.114 0.076 CID_115282 | ||
| 0.123 | 0.029 | 0.132 | Acetylcholine nicotinic antagonist | 0.132 0.026 CID_115282 | CID_115282 | |
| 0.099 | 0.008 | 0.099 | Sphingosine kinase 2 inhibitor | |||
| 0.152 | 0.061 | 0.158 | Neuropeptide Y1 antagonist | 0.158 0.054 CID_115282 | CID_115282 | |
| 0.132 | 0.043 | 0.15 | Nav1.4 sodium channel blocker | 0.15 0.034 CID_115282 | CID_115282 | |
| 0.13 | 0.043 | 0.143 | Transcription factor STAT6 inhibitor | 0.143 0.029 CID_115282 | CID_115282 | |
| 0.224 | 0.141 | 0.224 | Thyroid hormone antagonist | |||
| 0.135 | 0.054 | 0.135 | Acetylcholine muscarinic antagonist | |||
| 0.131 | 0.051 | 0.131 | Calcium channel N-type blocker | 0.101 0.094 CID_115282 | ||
| 0.183 | 0.104 | 0.183 | Potassium channel blocker | |||
| 0.226 | 0.148 | 0.227 | Interleukin 2 agonist | 0.227 0.147 CID_115282 | CID_115282 | |
| 0.078 | 0.005 | 0.078 | Acetyl-CoA transferase 1 inhibitor | 0.06 0.009 CID_115282 | ||
| 0.134 | 0.065 | 0.134 | Toll-Like receptor 2 antagonist | 0.132 0.066 CID_115282 | ||
| 0.083 | 0.015 | 0.083 | Sphingosine 1-phosphate receptor 3 antagonist | 0.059 0.039 CID_115282 | ||
| 0.08 | 0.013 | 0.08 | Nicotinic receptor alpha3 subunit antagonist | 0.068 0.016 CID_115282 | ||
| 0.084 | 0.017 | 0.084 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.064 0.036 CID_115282 | ||
| 0.079 | 0.013 | 0.097 | Nicotinic alpha3beta2 receptor antagonist | 0.097 0.008 CID_115282 | CID_115282 | |
| 0.136 | 0.072 | 0.136 | Calcium channel blocker | |||
| 0.091 | 0.028 | 0.107 | Neuronal nicotinic receptor antagonist | 0.107 0.022 CID_115282 | CID_115282 | |
| 0.095 | 0.033 | 0.095 | Interferon agonist | |||
| 0.074 | 0.013 | 0.074 | Prolyl endopeptidase inhibitor | 0.065 0.019 CID_115282 | ||
| 0.145 | 0.085 | 0.207 | Anticoagulant | 0.207 0.05 CID_115282 | CID_115282 | |
| 0.187 | 0.129 | 0.187 | Immunostimulant | 0.162 0.145 CID_115282 | ||
| 0.092 | 0.035 | 0.092 | Acetylcholine M4 receptor antagonist | |||
| 0.062 | 0.006 | 0.062 | Peptide deformylase inhibitor | |||
| 0.059 | 0.005 | 0.059 | Baculoviral IAP repeat-containing protein inhibitor | 0.058 0.007 CID_115282 | ||
| 0.073 | 0.019 | 0.073 | Prolactin release inhibitor | 0.06 0.054 CID_115282 | ||
| 0.082 | 0.031 | 0.082 | Phospholipase D inhibitor | |||
| 0.137 | 0.086 | 0.137 | Heat shock protein 70 antagonist | |||
| 0.077 | 0.027 | 0.077 | Interferon inducer | |||
| 0.054 | 0.004 | 0.054 | Adenosine uptake inhibitor | 0.033 0.031 CID_115282 | ||
| 0.07 | 0.022 | 0.07 | Glucosylceramidase inhibitor | 0.05 0.049 CID_115282 | ||
| 0.097 | 0.049 | 0.125 | Acetylcholine agonist | 0.125 0.035 CID_115282 | CID_115282 | |
| 0.136 | 0.089 | 0.136 | Ca2+-transporting ATPase inhibitor | |||
| 0.072 | 0.026 | 0.072 | Calcium channel T-type blocker | |||
| 0.053 | 0.008 | 0.053 | Prostaglandin EP4 antagonist | |||
| 0.109 | 0.066 | 0.109 | 5 Hydroxytryptamine 3A agonist | 0.108 0.067 CID_115282 | ||
| 0.1 | 0.057 | 0.1 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.111 | 0.069 | 0.111 | Calcium channel (voltage-sensitive) blocker | |||
| 0.118 | 0.078 | 0.118 | Cathepsin H inhibitor | |||
| 0.093 | 0.054 | 0.093 | Opioid antagonist | |||
| 0.197 | 0.158 | 0.275 | 5 Hydroxytryptamine uptake stimulant | 0.275 0.06 CID_115282 | CID_115282 | |
| 0.073 | 0.034 | 0.073 | Acetylcholine M2 receptor antagonist | |||
| 0.099 | 0.061 | 0.121 | Glutamate (mGluR7) agonist | 0.121 0.03 CID_115282 | CID_115282 | |
| 0.057 | 0.021 | 0.057 | CC chemokine 3 receptor antagonist | |||
| 0.088 | 0.053 | 0.145 | Hematopoietic | 0.145 0.016 CID_115282 | CID_115282 | |
| 0.057 | 0.024 | 0.057 | HCV NS3/NS4A protease inhibitor | 0.055 0.026 CID_115282 | ||
| 0.067 | 0.034 | 0.067 | Acetylcholine M5 receptor antagonist | |||
| 0.066 | 0.034 | 0.104 | Bombesin 1 receptor agonist | 0.104 0.016 CID_115282 | CID_115282 | |
| 0.127 | 0.097 | 0.127 | Diuretic | |||
| 0.056 | 0.027 | 0.056 | Potassium channel (Inward rectifier) blocker | |||
| 0.052 | 0.024 | 0.052 | Dopamine D5 antagonist | |||
| 0.085 | 0.059 | 0.085 | Calcium antagonist | |||
| 0.058 | 0.031 | 0.065 | Nicotinic receptor alpha7 subunit antagonist | 0.065 0.024 CID_115282 | CID_115282 | |
| 0.041 | 0.016 | 0.041 | Ceramide glucosyltransferase inhibitor | |||
| 0.043 | 0.018 | 0.043 | Glucose-6-phosphate dehydrogenase inhibitor | 0.037 0.027 CID_115282 | ||
| 0.058 | 0.034 | 0.058 | 5 Hydroxytryptamine 7 agonist | |||
| 0.093 | 0.068 | 0.093 | Sphingomyelinase inhibitor | |||
| 0.038 | 0.013 | 0.038 | Epoxide hydrolase 1 inhibitor | 0.031 0.02 CID_115282 | ||
| 0.034 | 0.01 | 0.034 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.028 0.018 CID_115282 | ||
| 0.155 | 0.132 | 0.155 | Hypolipemic | |||
| 0.042 | 0.019 | 0.042 | Delayed rectifier potassium channel blocker | |||
| 0.082 | 0.06 | 0.082 | Histamine H2 receptor antagonist | |||
| 0.167 | 0.145 | 0.204 | 5 Hydroxytryptamine 3E antagonist | 0.204 0.055 CID_115282 | CID_115282 | |
| 0.065 | 0.043 | 0.065 | 5 Hydroxytryptamine 1D antagonist | |||
| 0.063 | 0.042 | 0.088 | Histone deacetylase SIRT3 inhibitor | 0.088 0.014 CID_115282 | CID_115282 | |
| 0.026 | 0.005 | 0.026 | Baculoviral IAP repeat-containing protein 3 inhibitor | 0.025 0.005 CID_115282 | ||
| 0.102 | 0.083 | 0.102 | Acetylcholine release stimulant | |||
| 0.082 | 0.064 | 0.082 | Histamine N-methyltransferase inhibitor | |||
| 0.087 | 0.068 | 0.087 | Antihistaminic | |||
| 0.049 | 0.031 | 0.049 | Cytokine production stimulant | |||
| 0.052 | 0.034 | 0.052 | Chemokine receptor agonist | |||
| 0.07 | 0.053 | 0.07 | Aminopeptidase I inhibitor | 0.07 0.053 CID_115282 | ||
| 0.07 | 0.053 | 0.07 | Cathepsin G inhibitor | |||
| 0.044 | 0.026 | 0.055 | Histone deacetylase 8 inhibitor | 0.055 0.019 CID_115282 | CID_115282 | |
| 0.056 | 0.039 | 0.056 | Acetyl-CoA transferase 2 inhibitor | |||
| 0.052 | 0.035 | 0.052 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.052 | 0.035 | 0.052 | Cannabinoid CB2 receptor antagonist | |||
| 0.051 | 0.034 | 0.051 | Sigma receptor antagonist | |||
| 0.113 | 0.097 | 0.119 | Toll-Like receptor antagonist | 0.119 0.085 CID_115282 | CID_115282 | |
| 0.124 | 0.108 | 0.154 | Thiol protease inhibitor | 0.154 0.065 CID_115282 | CID_115282 | |
| 0.07 | 0.055 | 0.07 | Thrombin inhibitor | |||
| 0.026 | 0.012 | 0.026 | 5 Hydroxytryptamine 4 agonist | |||
| 0.052 | 0.039 | 0.055 | Alpha-mannosidase inhibitor | 0.055 0.035 CID_115282 | CID_115282 | |
| 0.075 | 0.063 | 0.128 | Acetylcholine nicotinic agonist | 0.128 0.024 CID_115282 | CID_115282 | |
| 0.043 | 0.031 | 0.043 | Histamine H3 receptor antagonist | |||
| 0.075 | 0.065 | 0.075 | Opioid kappa receptor antagonist | |||
| 0.062 | 0.052 | 0.062 | Opioid mu receptor antagonist | |||
| 0.148 | 0.139 | 0.148 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.088 | 0.079 | 0.112 | Electrolyte absorption antagonist | 0.112 0.043 CID_115282 | CID_115282 | |
| 0.021 | 0.012 | 0.021 | Apolipoprotein B inhibitor | |||
| 0.068 | 0.06 | 0.077 | Orexin receptor 1 antagonist | 0.077 0.039 CID_115282 | CID_115282 | |
| 0.055 | 0.048 | 0.055 | Acetylcholine M3 receptor antagonist | |||
| 0.023 | 0.017 | 0.023 | Aminopeptidase P inhibitor | |||
| 0.011 | 0.005 | 0.011 | Baculoviral IAP repeat-containing protein 2 inhibitor | 0.01 0.005 CID_115282 | ||
| 0.053 | 0.047 | 0.056 | Cathepsin L inhibitor | 0.056 0.042 CID_115282 | CID_115282 | |
| 0.029 | 0.023 | 0.029 | Potassium channel subfamily K member 3 blocker | |||
| 0.075 | 0.07 | 0.075 | Histamine antagonist | |||
| 0.018 | 0.014 | 0.025 | Complement factor D inhibitor | 0.025 0.005 CID_115282 | CID_115282 | |
| 0.038 | 0.034 | 0.046 | Oxytocin agonist | 0.046 0.027 CID_115282 | CID_115282 | |
| 0.026 | 0.023 | 0.028 | HCV NS5A inhibitor | 0.028 0.02 CID_115282 | CID_115282 | |
| 0.057 | 0.055 | 0.057 | Dopamine agonist | |||
| 0.084 | 0.083 | 0.084 | Toll-Like receptor 3 antagonist | |||
| 0.04 | 0.039 | 0.183 | Dihydroorotase inhibitor | 0.183 0.003 CID_115282 | CID_115282 | |
| 0.069 | 0.068 | 0.073 | Vanilloid 4 agonist | 0.073 0.057 CID_115282 | CID_115282 | |
| 0.062 | 0.064 | 0.063 | Protein kinase C beta inhibitor | 0.063 0.062 CID_115282 | CID_115282 | |
| 0.059 | 0.061 | 0.069 | Orexin receptor antagonist | 0.069 0.041 CID_115282 | CID_115282 | |
| 0.033 | 0.035 | 0.036 | Cathepsin L1 inhibitor | 0.036 0.031 CID_115282 | CID_115282 | |
| 0.053 | 0.056 | 0.1 | NMDA 2C receptor antagonist | 0.1 0.016 CID_115282 | CID_115282 | |
| 0.047 | 0.051 | 0.07 | Plasminogen activator inhibitor | 0.07 0.032 CID_115282 | CID_115282 | |
| 0.069 | 0.073 | 0.07 | Cell adhesion molecule inhibitor | 0.07 0.069 CID_115282 | CID_115282 | |
| 0.025 | 0.029 | 0.027 | Caspase 2 inhibitor | 0.027 0.026 CID_115282 | CID_115282 | |
| 0.08 | 0.084 | 0.096 | Polo-like kinase-1 inhibitor | 0.096 0.051 CID_115282 | CID_115282 | |
| 0.03 | 0.038 | 0.04 | Nicotinic receptor beta4 subunit antagonist | 0.04 0.023 CID_115282 | CID_115282 | |
| 0.046 | 0.055 | 0.075 | Dipeptidyl peptidase inhibitor | 0.075 0.016 CID_115282 | CID_115282 | |
| 0.048 | 0.058 | 0.054 | Carbonic anhydrase stimulant | 0.054 0.048 CID_115282 | CID_115282 | |
| 0.165 | 0.176 | 0.204 | DNA synthesis inhibitor | 0.204 0.116 CID_115282 | CID_115282 | |
| 0.075 | 0.087 | 0.084 | T cell inhibitor | 0.084 0.054 CID_115282 | CID_115282 | |
| 0.09 | 0.102 | 0.096 | Proteasome inhibitor | 0.096 0.093 CID_115282 | CID_115282 | |
| 0.038 | 0.051 | 0.051 | Dipeptidyl peptidase IV inhibitor | 0.051 0.019 CID_115282 | CID_115282 | |
| 0.016 | 0.029 | 0.022 | Glutamate (mGluR1a) agonist | 0.022 0.016 CID_115282 | CID_115282 | |
| 0.027 | 0.043 | 0.035 | Melanocortin 1 antagonist | 0.035 0.029 CID_115282 | CID_115282 | |
| 0.051 | 0.07 | 0.075 | Corticotropin releasing factor 2 receptor antagonist | 0.075 0.022 CID_115282 | CID_115282 | |
| 0.083 | 0.105 | 0.153 | Hedgehog signaling inhibitor | 0.153 0.023 CID_115282 | CID_115282 | |
| 0.024 | 0.049 | 0.035 | Dipeptidyl peptidase II inhibitor | 0.035 0.019 CID_115282 | CID_115282 | |
| 0.016 | 0.041 | 0.025 | Melanocortin 5 antagonist | 0.025 0.019 CID_115282 | CID_115282 | |
| 0.039 | 0.064 | 0.078 | Nicotinic neuronal receptor agonist | 0.078 0.023 CID_115282 | CID_115282 | |
| 0.018 | 0.044 | 0.026 | Glutamate (mGluR1) agonist | 0.026 0.015 CID_115282 | CID_115282 | |
| 0.032 | 0.06 | 0.061 | Melanocortin antagonist | 0.061 0.02 CID_115282 | CID_115282 | |
| 0.039 | 0.069 | 0.067 | Nicotinic receptor alpha4 subunit antagonist | 0.067 0.018 CID_115282 | CID_115282 | |
| 0.004 | 0.038 | 0.012 | Melatonin 5 antagonist | 0.012 0.007 CID_115282 | CID_115282 | |
| 0.045 | 0.079 | 0.053 | Cathepsin E inhibitor | 0.053 0.052 CID_115282 | CID_115282 | |
| 0.023 | 0.062 | 0.062 | Melanocortin 4 antagonist | 0.062 0.018 CID_115282 | CID_115282 | |
| 0.073 | 0.112 | 0.096 | Potassium channel (Voltage-sensitive) activator | 0.096 0.059 CID_115282 | CID_115282 | |
| 0.012 | 0.051 | 0.025 | Imidazoline I1 receptor antagonist | 0.025 0.01 CID_115282 | CID_115282 | |
| 0.016 | 0.057 | 0.044 | Gonadotropin-releasing hormone receptor antagonist | 0.044 0.019 CID_115282 | CID_115282 | |
| 0.072 | 0.113 | 0.101 | Ferrochelatase inhibitor | 0.101 0.07 CID_115282 | CID_115282 | |
| 0.046 | 0.091 | 0.062 | Gonadotropin-releasing hormone receptor agonist | 0.062 0.035 CID_115282 | CID_115282 | |
| 0.036 | 0.084 | 0.122 | CXC chemokine 4 receptor antagonist | 0.122 0.02 CID_115282 | CID_115282 | |
| 0.014 | 0.066 | 0.046 | Endothelial nitric-oxide synthase inhibitor | 0.046 0.01 CID_115282 | CID_115282 | |
| 0.063 | 0.118 | 0.088 | MAP kinase kinase 7 inhibitor | 0.088 0.028 CID_115282 | CID_115282 | |
| 0.063 | 0.119 | 0.079 | Factor XII inhibitor | 0.079 0.068 CID_115282 | CID_115282 | |
| 0.007 | 0.064 | 0.017 | Somatostatin 2 agonist | 0.017 0.008 CID_115282 | CID_115282 | |
| 0.087 | 0.147 | 0.177 | Histone deacetylase SIRT1 inhibitor | 0.177 0.041 CID_115282 | CID_115282 | |
| 0.023 | 0.083 | 0.038 | Membrane dipeptidase inhibitor | 0.038 0.029 CID_115282 | CID_115282 | |
| 0.068 | 0.129 | 0.139 | Nitric-oxide synthase inhibitor | 0.139 0.028 CID_115282 | CID_115282 | |
| 0.104 | 0.167 | 0.132 | Adenylate cyclase stimulant | 0.132 0.098 CID_115282 | CID_115282 | |
| 0.075 | 0.143 | 0.139 | Lck kinase inhibitor | 0.139 0.072 CID_115282 | CID_115282 | |
| 0.012 | 0.079 | 0.019 | Somatostatin 3 agonist | 0.019 0.012 CID_115282 | CID_115282 | |
| 0.099 | 0.172 | 0.191 | Hemostatic | 0.191 0.036 CID_115282 | CID_115282 | |
| 0.022 | 0.099 | 0.033 | ADAM10 endopeptidase inhibitor | 0.033 0.024 CID_115282 | CID_115282 | |
| 0.054 | 0.132 | 0.151 | Inducible nitric-oxide synthase inhibitor | 0.151 0.016 CID_115282 | CID_115282 | |
| 0.136 | 0.215 | 0.152 | MAP kinase kinase 5 inhibitor | 0.152 0.143 CID_115282 | CID_115282 | |
| 0.065 | 0.144 | 0.096 | GABA C receptor rho-1 antagonist | 0.096 0.068 CID_115282 | CID_115282 | |
| 0.005 | 0.084 | 0.028 | Melatonin 3 antagonist | 0.028 0.009 CID_115282 | CID_115282 | |
| 0.039 | 0.119 | 0.065 | Polo-like kinase-2 inhibitor | 0.065 0.058 CID_115282 | CID_115282 | |
| 0.079 | 0.16 | 0.213 | Thrombolytic | 0.213 0.046 CID_115282 | CID_115282 | |
| 0.024 | 0.113 | 0.065 | Phenylethanolamine N methyltransferase inhibitor | 0.065 0.006 CID_115282 | CID_115282 | |
| 0.016 | 0.106 | 0.026 | Motilin receptor antagonist | 0.026 0.022 CID_115282 | CID_115282 | |
| 0.01 | 0.103 | 0.031 | Motilin receptor agonist | 0.031 0.009 CID_115282 | CID_115282 | |
| 0.013 | 0.107 | 0.036 | Somatostatin agonist | 0.036 0.019 CID_115282 | CID_115282 | |
| 0.03 | 0.125 | 0.055 | Androgen agonist | 0.055 0.048 CID_115282 | CID_115282 | |
| 0.025 | 0.121 | 0.05 | CC chemokine 4 receptor antagonist | 0.05 0.028 CID_115282 | CID_115282 | |
| 0.005 | 0.101 | 0.035 | Growth hormone secretagogue receptor agonist | 0.035 0.024 CID_115282 | CID_115282 | |
| 0.069 | 0.166 | 0.131 | Alpha-N-acetylglucosaminidase inhibitor | 0.131 0.068 CID_115282 | CID_115282 | |
| 0.009 | 0.107 | 0.063 | Dipeptidyl peptidase I inhibitor | 0.063 0.006 CID_115282 | CID_115282 | |
| 0.05 | 0.153 | 0.095 | Potassium channel activator | 0.095 0.053 CID_115282 | CID_115282 | |
| 0.008 | 0.113 | 0.036 | Nicotinic alpha4beta2 receptor agonist | 0.036 0.011 CID_115282 | CID_115282 | |
| 0.005 | 0.118 | 0.016 | Nicotinic alpha4 receptor agonist | 0.016 0.011 CID_115282 | CID_115282 | |
| 0.091 | 0.205 | 0.124 | GABA C receptor rho-2 antagonist | 0.124 0.117 CID_115282 | CID_115282 | |
| 0.059 | 0.177 | 0.096 | GABA C receptor antagonist | 0.096 0.085 CID_115282 | CID_115282 | |
| 0.023 | 0.146 | 0.069 | Cyclin A1 inhibitor | 0.069 0.024 CID_115282 | CID_115282 | |
| 0.157 | 0.294 | 0.187 | MAP kinase kinase 3 inhibitor | 0.187 0.165 CID_115282 | CID_115282 | |
| 0.161 | 0.313 | 0.219 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.219 0.117 CID_115282 | CID_115282 | |
| 0.007 | 0.172 | 0.032 | Nicotinic alpha3beta4 receptor agonist | 0.032 0.018 CID_115282 | CID_115282 | |
| 0.015 | 0.182 | 0.04 | Integrin alpha2 antagonist | 0.04 0.02 CID_115282 | CID_115282 | |
| 0.07 | 0.243 | 0.125 | MAP3K9 inhibitor | 0.125 0.103 CID_115282 | CID_115282 | |
| 0.02 | 0.193 | 0.075 | 5 Hydroxytryptamine 2A agonist | 0.075 0.032 CID_115282 | CID_115282 | |
| 0.028 | 0.205 | 0.064 | NMDA receptor agonist | 0.064 0.042 CID_115282 | CID_115282 | |
| 0.033 | 0.21 | 0.072 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.072 0.055 CID_115282 | CID_115282 | |
| 0.016 | 0.195 | 0.038 | Tryptophan 5 hydroxylase inhibitor | 0.038 0.019 CID_115282 | CID_115282 | |
| 0.026 | 0.213 | 0.066 | I kappa B kinase 2 inhibitor | 0.066 0.037 CID_115282 | CID_115282 | |
| 0.123 | 0.319 | 0.208 | Nitric-oxide synthase stimulant | 0.208 0.077 CID_115282 | CID_115282 | |
| 0.078 | 0.281 | 0.144 | Tumour necrosis factor antagonist | 0.144 0.109 CID_115282 | CID_115282 | |
| 0.038 | 0.25 | 0.123 | GABA C receptor agonist | 0.123 0.048 CID_115282 | CID_115282 | |
| 0.039 | 0.286 | 0.115 | Sodium channel (voltage-gated) blocker | 0.115 0.09 CID_115282 | CID_115282 | |
| 0.007 | 0.265 | 0.051 | 5 Hydroxytryptamine 2 agonist | 0.051 0.037 CID_115282 | CID_115282 | |
| 0.097 | 0.375 | 0.206 | Antiobesity | 0.206 0.202 CID_115282 | CID_115282 | |
| 0.024 | 0.307 | 0.076 | I kappa B kinase inhibitor | 0.076 0.067 CID_115282 | CID_115282 | |
| 0.012 | 0.312 | 0.036 | 5 Hydroxytryptamine 2B agonist | 0.036 0.033 CID_115282 | CID_115282 | |
| 0.005 | 0.329 | 0.061 | 5 Hydroxytryptamine 2C agonist | 0.061 0.02 CID_115282 | CID_115282 | |
| 0.019 | 0.348 | 0.081 | Pim-3 kinase inhibitor | 0.081 0.076 CID_115282 | CID_115282 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |